AUG 17, 2016 04:44 PM PDT

Patients bring superbugs to the hospital

WRITTEN BY: Kerry Evans
1 5 419
It is estimated that, in Germany, 15,000 people die from hospital-acquired “superbug” infections each year. A new study by University of Cologne researchers reveals that, often, patients bring these superbugs into the hospital from their own homes.

The researchers were particularly interested in one group of superbugs - the 3GCREBs (third-generation cephalosporin-resistant Enterobacteriaceae).
Patients bring superbugs into the hospital.
Cephalosporins are some of the most widely-used antibiotics these days. They work by inhibiting bacterial cell wall synthesis. Bacteria are fighting back, however. Enzymes called beta-lactamases degrade cephalosporins, making them harmless to the bacteria.

The group surveyed over 4,000 adults who were being admitted at 6 German University Hospitals. They tested each patient for multidrug resistant Enterobacteriaceae (stool samples or rectal swabs). These bacteria are harmless if they remain in your gut - where they normally live. When passed from one person to the other by “smear infection”, they can cause urinary tract infections, for example.

According to study author Axel Hamprecht, “we were surprised that on hospital admission almost every tenth patient is colonised with multidrug-resistant pathogens”. To be precise, 416 of 4,376 adults, or 9.5%, were 3GCREB carriers. E. coli was the most common species found, with an incidence of 79.1%. A smaller number of patients, 0.11%, were carriers of carbapenemase-producing Enterobacteriaceae. Carbapenemases are a type of beta-lactamase that can degrade a number of antibiotics, including penicillins, cephalosporins, and carbapenems.

They also identified a handful of factors that make it more likely for you to be a superbug-carrier. These include antibiotic use within the last 6 months, treatment for gastroesophageal reflux disease, residing in a longterm care facility, and traveling outside of Europe (remember, this study was conducted in Germany).

Another important point is that these superbug-carriers were not ICU patients. That is, you don’t have to be severely ill to risk contracting or spreading a superbug infection.

According to Hamprecht, 3GCREBs may be the next superbugs to worry about. “With so many people affected, the strategy of isolating patients within the hospitals no longer works. Additionally, in contrast to other groups of multidrug-resistant bacteria such as MRSA (Methicillin-resistant Staphylococcus aureus) strains, standardised sanitation measures for 3GCREB have not been established.”
 


Sources: Journal of Antimicrobial Chemotherapy, MedicalXpress
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
JUN 14, 2018
Microbiology
JUN 14, 2018
The Rise of Carbapenem Resistance
European scientists are warning clinicians about a dangerous group of microbes that resist the effects of drugs used as a last resort.
JUN 19, 2018
Microbiology
JUN 19, 2018
The Impact of Antibiotics on Gut Microbes
Antibiotics had a dramatic impact on the microbes of the GI tract in a research model.
JUL 04, 2018
Drug Discovery
JUL 04, 2018
Discovery of New Properties of an Anti-Tuberculosis Drug
  Investigators at the University of Otago found novel properties of a new anti-tuberculosis drug which may inspire more new drugs to treat tuberculos
JUL 27, 2018
Microbiology
JUL 27, 2018
Making Accurate Assessments of the Environmental Impact of Pollution
Without the right experimental design, behavioral testing can easily produce the wrong results.
AUG 06, 2018
Immunology
AUG 06, 2018
Maternal Dengue Immunity Protects Against Infant Zika Infection
Maternal Dengue immunity produces CD8+ T cells that protect against fetal Zika infection preventing zika-related malformations.
AUG 08, 2018
Microbiology
AUG 08, 2018
Use of Probiotics Linked to Severe Bloating, Brain Fog
Gut bacteria can have a powerful effect on brain function.
Loading Comments...